Global medtech executive with over $850M full P&L management experience, skilled in strategic growth planning, cross-functional team leadership, and successful commercialization of novel medical technologies. Served in key roles on teams bringing to market new implantable, capital equipment, and wearable technologies from pre-approval or early stage post-approval through the regulatory process, clinical trial strategy and evidence generation, reimbursement, market access and development, and worldwide commercialization at scale to create new categories, first with cardiac resynchronization therapy, then the MR compatible infusion pump and vital signs monitoring system, followed by the wearable defibrillator, and most recently a wearable pulmonary fluid management system for patients with heart failure.